Antibody-Guided Alpha Radiation Effectively Damages Fungal Biofilms
- 1 June 2006
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (6), 2132-2136
- https://doi.org/10.1128/aac.00120-06
Abstract
The use of indwelling medical devices—pacemakers, prosthetic joints, catheters—is rapidly growing and is often complicated by infections with biofilm-forming microbes that are resistant to antimicrobial agents and host defense mechanisms. We investigated for the first time the use of microbe-specific monoclonal antibodies (MAbs) as delivery vehicles for targeting biofilms with cytocidal radiation. MAb 18B7 (immunoglobulin G1 [IgG1]), which binds to capsular polysaccharides of the human pathogenic fungus Cryptococcus neoformans , penetrated cryptococcal biofilms, as shown by confocal microscopy. When the alpha radiation-emitter 213-Bismuth ( 213 Bi) was attached to MAb 18B7 and the radiolabeled MAb was added to C. neoformans biofilms, there was a 50% reduction in biofilm metabolic activity. In contrast, when the IgM MAb 13F1 labeled with 213 Bi was used there was no penetration of the fungal biofilm and no damage. Unlabeled 18B7, 213 Bi-labeled nonspecific MAbs, and gamma and beta types of radiation did not have an effect on biofilms. The lack of efficacy of gamma and beta radiation probably reflects the radioprotective properties of polysaccharide biofilm matrix. Our results indicate that C. neoformans biofilms are susceptible to treatment with antibody-targeted alpha radiation, suggesting a novel option for the prevention or treatment of microbial biofilms on indwelling medical devices.Keywords
This publication has 25 references indexed in Scilit:
- Antibodies as delivery vehicles for radioimmunotherapy of infectious diseasesExpert Opinion on Drug Delivery, 2005
- Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective EfficacyInfection and Immunity, 2005
- Aminoglycoside antibiotics induce bacterial biofilm formationNature, 2005
- 131I-Tositumomab Therapy as Initial Treatment for Follicular LymphomaNew England Journal of Medicine, 2005
- Penetration of Candida Biofilms by Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2004
- Feasibility of Radioimmunotherapy of Experimental Pneumococcal InfectionAntimicrobial Agents and Chemotherapy, 2004
- Evaluation of Acute Hematologic and Long-Term Pulmonary Toxicities of Radioimmunotherapy of Cryptococcus neoformans Infection in Murine ModelsAntimicrobial Agents and Chemotherapy, 2004
- Emerging Infectious Diseases in Russia, 1990-1999Emerging Infectious Diseases, 2001
- Radioprotection by Dmso Against the Biological Effects of Incorporated Radionuclides in Vivo: Comparison with other radioprotectors and evidence for indirect action of Auger electronsActa Oncologica, 1996
- Ventriculoatrial Shunt Infection Due to Cryptococcus neoformans: An Ultrastructural and Quantitative Microbiological StudyNeurosurgery, 1986